These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17085853)

  • 1. Update on the management of polycystic ovary syndrome.
    Krysiak R; Okopień B; Gdula-Dymek A; Herman ZS
    Pharmacol Rep; 2006; 58(5):614-25. PubMed ID: 17085853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advance in treatment of polycystic ovary syndrome].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 Dec; 19(114):848-54. PubMed ID: 16521439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE
    Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic approach for metabolic disorders and infertility in women with PCOS.
    Morgante G; Massaro MG; Di Sabatino A; Cappelli V; De Leo V
    Gynecol Endocrinol; 2018 Jan; 34(1):4-9. PubMed ID: 28850273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minireview: Up-date management of non responder to clomiphene citrate in polycystic ovary syndrome.
    Amin M; Abdel-Kareem O; Takekida S; Moriyama T; Abd el-Aal G; Maruo T
    Kobe J Med Sci; 2003; 49(3-4):59-73. PubMed ID: 14676484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?
    Cheang KI; Nestler JE
    Reprod Biomed Online; 2004 Apr; 8(4):440-7. PubMed ID: 15149568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine and metabolic characteristics in polycystic ovary syndrome.
    Glintborg D
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
    Nestler JE
    Semin Reprod Endocrinol; 1997 May; 15(2):111-22. PubMed ID: 9165656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.
    Balen AH; Morley LC; Misso M; Franks S; Legro RS; Wijeyaratne CN; Stener-Victorin E; Fauser BC; Norman RJ; Teede H
    Hum Reprod Update; 2016 Nov; 22(6):687-708. PubMed ID: 27511809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome and female reproduction.
    Elghblawi E
    Br J Nurs; 2007 Oct 11-24; 16(18):1118-21. PubMed ID: 18073681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of polycystic ovary syndrome.
    Ajossa S; Guerriero S; Paoletti AM; Orrù M; Melis GB
    Minerva Ginecol; 2004 Feb; 56(1):15-26. PubMed ID: 14973407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in polycystic ovary syndrome treatment: metformin and ovarian diathermy.
    Leclair C; Patton PE
    Curr Womens Health Rep; 2002 Oct; 2(5):333-7. PubMed ID: 12215305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E; Kiapekou E; Loutradis D
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.
    De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F
    Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategies in PCOS patients.
    Tauchert S; Ludwig AK; Diedrich K; Weiss JM
    Reprod Biomed Online; 2005 Jun; 10 Suppl 3():67-74. PubMed ID: 23577418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of Delayed Fertility Therapy With Preconception Weight Loss Over Immediate Therapy in Obese Women With PCOS.
    Legro RS; Dodson WC; Kunselman AR; Stetter CM; Kris-Etherton PM; Williams NI; Gnatuk CL; Estes SJ; Allison KC; Sarwer DB; Diamond MP; Schlaff WD; Casson PR; Christman GM; Barnhart KT; Bates GW; Usadi R; Lucidi S; Baker V; Zhang H; Eisenberg E; Coutifaris C; Dokras A
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2658-66. PubMed ID: 27172435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-lowering agents in the management of polycystic ovary syndrome.
    De Leo V; la Marca A; Petraglia F
    Endocr Rev; 2003 Oct; 24(5):633-67. PubMed ID: 14570747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.